Appointment of Members of Senior Executive Service Performance Review Board, 42318 [2018-18022]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
42318
Federal Register / Vol. 83, No. 162 / Tuesday, August 21, 2018 / Notices
contained therein, is available for
inspection during official business
hours (8:45 a.m. to 5:15 p.m.) in the
Office of the Secretary, U.S.
International Trade Commission, 500 E
Street SW, Room 112, Washington, DC
20436, telephone (202) 205–2000.
Hearing impaired individuals are
advised that information on this matter
can be obtained by contacting the
Commission’s TDD terminal on (202)
205–1810. Persons with mobility
impairments who will need special
assistance in gaining access to the
Commission should contact the Office
of the Secretary at (202) 205–2000.
General information concerning the
Commission may also be obtained by
accessing its internet server at https://
www.usitc.gov. The public record for
this investigation may be viewed on the
Commission’s electronic docket (EDIS)
at https://edis.usitc.gov.
FOR FURTHER INFORMATION CONTACT:
Katherine Hiner, The Office of the
Secretary, Docket Services, U.S.
International Trade Commission,
telephone (202) 205–1802.
SUPPLEMENTARY INFORMATION:
Authority: The authority for
institution of this investigation is
contained in section 337 of the Tariff
Act of 1930, as amended, 19 U.S.C.
1337, and in section 210.10 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.10 (2018).
Scope of Investigation: Having
considered the amended complaint, the
U.S. International Trade Commission,
on August 15, 2018, ordered that—
(1) Pursuant to subsection (b) of
section 337 of the Tariff Act of 1930, as
amended, an investigation be instituted
to determine whether there is a
violation of subsection (a)(1)(B) of
section 337 in the importation into the
United States, the sale for importation,
or the sale within the United States after
importation of products identified in
paragraph (2) by reason of infringement
of one or more of claims 1–10, 12, 16,
17, 19–28, and 30–42 of the ’407 patent
and claims 1–9, 11, 13, 14, 17–22 and
24–29 of the ’058 patent; and whether
an industry in the United States exists
as required by subsection (a)(2) of
section 337;
(2) Pursuant to section 210.10(b)(1) of
the Commission’s Rules of Practice and
Procedure, 19 CFR 210.10(b)(1), the
plain language description of the
accused products or category of accused
products, which defines the scope of the
investigation, is ‘‘lithography machines
that use projection objectives to project
circuit patterns drawn on a ‘mask’ or
‘reticle’ onto a photoresist on a silicon
wafer, components of the lithography
VerDate Sep<11>2014
17:31 Aug 20, 2018
Jkt 244001
machines, and systems related to the
operation of the lithography machines’’;
(3) For the purpose of the
investigation so instituted, the following
are hereby named as parties upon which
this notice of investigation shall be
served:
(a) The complainants are: Carl Zeiss
SMT GmbH, Carl-Zeiss-Strabe 22,
Oberkochen, Germany 73447.
(b) The respondents are the following
entities alleged to be in violation of
section 337, and are the parties upon
which the amended complaint is to be
served:
Nikon Corporation, Shingawa Intercity
Tower C, 2–15–3 Konan, Minato-ku,
Tokyo 108–6290, Japan.
Nikon Research Corporation of America,
1399 Shoreway Road, Belmont, CA
94002–4107.
Nikon Precision Inc., 1399 Shoreway
Road, Belmont, CA 94002.
(4) For the investigation so instituted,
the Chief Administrative Law Judge,
U.S. International Trade Commission,
shall designate the presiding
Administrative Law Judge.
The Office of Unfair Import
Investigations will not participate as a
party in this investigation.
The Chief Administrative Law Judge
is authorized to consolidate Inv. No.
337–TA–1128 with Inv. No. 337–TA–
1129 if he deems it appropriate.
Responses to the amended complaint
and the notice of investigation must be
submitted by the named respondents in
accordance with section 210.13 of the
Commission’s Rules of Practice and
Procedure, 19 CFR 210.13. Pursuant to
19 CFR 201.16(e) and 210.13(a), such
responses will be considered by the
Commission if received not later than 20
days after the date of service by the
Commission of the amended complaint
and the notice of investigation.
Extensions of time for submitting
responses to the amended complaint
and the notice of investigation will not
be granted unless good cause therefor is
shown.
Failure of a respondent to file a timely
response to each allegation in the
amended complaint and in this notice
may be deemed to constitute a waiver of
the right to appear and contest the
allegations of the amended complaint
and this notice, and to authorize the
administrative law judge and the
Commission, without further notice to
the respondent, to find the facts to be as
alleged in the amended complaint and
this notice and to enter an initial
determination and a final determination
containing such findings, and may
result in the issuance of an exclusion
order or a cease and desist order or both
directed against the respondent.
PO 00000
Frm 00067
Fmt 4703
Sfmt 4703
By order of the Commission.
Issued: August 15, 2018.
Lisa Barton,
Secretary to the Commission.
[FR Doc. 2018–17950 Filed 8–20–18; 8:45 am]
BILLING CODE 7020–02–P
EXECUTIVE OFFICE OF THE
PRESIDENT
OFFICE OF NATIONAL DRUG
CONTROL POLICY
Appointment of Members of Senior
Executive Service Performance Review
Board
Office of National Drug Control
Policy (ONDCP), Executive Office of the
President.
ACTION: Notice of Appointments.
AGENCY:
The following persons have
been appointed to the ONDCP Senior
Executive Service Performance Review
Board: Martha Gagne (as Chair), Michael
Gottlieb, James Olson, and Kemp
Chester.
FOR FURTHER INFORMATION CONTACT:
Michael Passante, Deputy General
Counsel, (202) 395–6709, Office of
National Drug Control Policy, Executive
Office of the President, 750 17th Street
NW, Washington, DC 20503.
SUMMARY:
Dated: August 16, 2018.
Michael Passante,
Deputy General Counsel.
[FR Doc. 2018–18022 Filed 8–20–18; 8:45 am]
BILLING CODE 3280–F5–P
NATIONAL SCIENCE FOUNDATION
Sunshine Act Meetings
The National Science Board, pursuant
to NSF regulations (45 CFR part 614),
the National Science Foundation Act, as
amended (42 U.S.C. 1862n–5), and the
Government in the Sunshine Act (5
U.S.C. 552b), hereby gives notice of the
scheduling of a teleconference for the
transaction of National Science Board
business, as follows:
TIME AND DATE: Closed teleconference of
the Committee on Oversight of the
National Science Board, to be held
Monday, August 27, 2018 from 4:00
p.m. to 4:30 p.m. EDT.
PLACE: This meeting will be held by
teleconference at the National Science
Foundation, 2415 Eisenhower Avenue,
Alexandria, VA 22314.
STATUS: Closed.
MATTERS TO BE CONSIDERED: Chair’s
opening remarks; discussion of FY 2020
OIG budget request.
E:\FR\FM\21AUN1.SGM
21AUN1
]]>Agencies
[Federal Register Volume 83, Number 162 (Tuesday, August 21, 2018)]
[Notices]
[Page 42318]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-18022]
=======================================================================
-----------------------------------------------------------------------
EXECUTIVE OFFICE OF THE PRESIDENT
OFFICE OF NATIONAL DRUG CONTROL POLICY
Appointment of Members of Senior Executive Service Performance
Review Board
AGENCY: Office of National Drug Control Policy (ONDCP), Executive
Office of the President.
ACTION: Notice of Appointments.
-----------------------------------------------------------------------
SUMMARY: The following persons have been appointed to the ONDCP Senior
Executive Service Performance Review Board: Martha Gagne (as Chair),
Michael Gottlieb, James Olson, and Kemp Chester.
FOR FURTHER INFORMATION CONTACT: Michael Passante, Deputy General
Counsel, (202) 395-6709, Office of National Drug Control Policy,
Executive Office of the President, 750 17th Street NW, Washington, DC
20503.
Dated: August 16, 2018.
Michael Passante,
Deputy General Counsel.
[FR Doc. 2018-18022 Filed 8-20-18; 8:45 am]
BILLING CODE 3280-F5-P
